GE Healthcare to Acquire Clarient and Accelerate Expansion into Cancer Diagnostics

doi:10.3833/pdr.v2010i9.1404

Pharma Deals Review, Vol 2010, No 9 (2010)

GE Healthcare to Acquire Clarient and Accelerate Expansion into Cancer Diagnostics

Editorial Team

Abstract

GE Healthcare and Clarient Inc have signed an agreement by which GE will buy the latter for about USD 580 M. GE expects to get into the fast track to become a major player in developing new integrated tools for molecular diagnosis of cancer.

Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.